Scientists discover a way to kill off tumors in cancer treatment breakthrough

Apr 05, 2011

Scientists from the School of Pharmacy at Queen's University Belfast and Almac Discovery Ltd have developed a new treatment for cancer which rather than attacking tumours directly, prevents the growth of new blood vessels in tumours, starving them of oxygen and nutrients, thereby preventing their growth.

Targeting tumour is not a new concept, however, this drug attacks the blood vessels using an entirely different pathway and therefore could be useful for treating tumours which don't respond to or which are resistant to current therapies of this type.

Professor Tracy Robson and her research team at Queen's, in collaboration with researchers at Almac Discovery, developed a new drug to disrupt the tumour blood supply. They have demonstrated that this leads to highly effective inhibition of tumour growth in a number of models as reported this month in , a journal of the American Association for Cancer Research. Almac Discovery is developing the and expects to start clinical trials within the next year.

Professor Tracy Robson from the School of Pharmacy at Queen's explains: "By understanding the anti-angiogenic potential of the natural protein, FKBPL, we have been able to develop small peptide-based drugs that could be delivered to prevent tumour growth by cutting off their blood supply. This is highly effective in models of prostate and .

"However, this also has the potential for the treatment of any solid tumour and we're excited about continuing to work with Almac Discovery as this drug enters clinical trials."

Dr Stephen Barr, President and Managing Director of Almac Discovery said: "This is a first class example of a collaboration between a university and industry to produce a novel approach to that has a real chance of helping patients".

The Almac Discovery / Queen's University drug is currently undergoing preclinical development and may provide a first-in-class therapy for targeting tumour angiogenesis by an entirely different pathway to those agents currently approved.

Explore further: Exercising restraint to stall tumor growth

Provided by Queen's University Belfast

4.8 /5 (13 votes)

Related Stories

More blood vessels in hormone-resistant prostate tumors

Dec 15, 2009

Patients with advanced prostate cancer are often treated with hormones, but when the tumours start growing again they have more and different blood vessels, reveals a thesis from the Sahlgrenska Academy, at the University ...

Innovative method to starve tumors

Feb 11, 2009

The development of cancerous tumours is highly dependent on the nutrients the tumours receive through the blood. The team of Dr. Janusz Rak, of the Research Institute of the McGill University Health Centre (MUHC) at the Montreal ...

A new cancer vaccine starves tumors of blood

May 24, 2010

A DNA-vaccine that restricts the supply of blood to tumours has been developed by scientists at the Swedish medical university Karolinska Institutet. The vaccine slows the growth of breast cancer tumours in mice.

Socking it to cancer

Aug 02, 2006

An Australian research team has identified a gene that could be used to stop tumours growing by blocking their blood supply.

Scientists develop new drug to outflank cancer resistance

Dec 11, 2007

A new drug has shown promising results against breast and prostate cancer cells and tumours that are resistant to conventional hormone-based treatments, according to research published in the British Journal of ...

Recommended for you

Exercising restraint to stall tumor growth

4 minutes ago

Many proteins undergo an assembly line-style process of glycosylation as they travel from a cellular structure called the endoplasmic reticulum (ER) to the Golgi apparatus and on through its various compartments, ...

New tool to probe cancer's molecular make-up

23 hours ago

Scientists have shown how to better identify and measure vital molecules that control cell behaviour – paving the way for improved tools for diagnosis, prediction and monitoring of cancer.

Mayo Clinic offers at-home colon cancer test

Aug 26, 2014

Mayo Clinic is taking another step toward making detection of colorectal cancer as convenient as possible, announcing Monday an at-home kit that arrives and is sent back in the mail, stool sample included.

User comments : 7

Adjust slider to filter visible comments by rank

Display comments: newest first

nanotech_republika_pl
not rated yet Apr 05, 2011
But cutting the blood supply from the tissue where the cancer grows, you are killing, first of all, the fibroblasts, not the cancer cells, so you're killing the patient body that way. There was a story on this website short time ago.
Jaeherys
not rated yet Apr 05, 2011
By cutting off the blood supply the tumour would die as well would it not? But it does sound like it only reduces the blood flow to the tomour.

They have demonstrated that this leads to highly effective inhibition of tumour growth in a number of models


fuviss_co_uk
5 / 5 (1) Apr 05, 2011
Every day we're closer to extermination of cancer

Good news
jtdrexel
not rated yet Apr 05, 2011
I take it that this drug would be administered directly to the cancerous tissue? Or is the drug a targeted molecule to the cancerous tissue?
MattyC1989
not rated yet Apr 06, 2011
By cutting off the blood flow, or antiangiogenic therapy you essentially cut the nutrients off to the cancerous growth. Kind of like cutting the roots off a plant. Yes, you will kill existing parts of the body that aren't considered cancerous but in very small amounts; furthermore, the alternatives such as chemotherapy or radiation also kill areas of the body in which aren't cancerous. The anti-angiogenic therapy is a far less detrimental way of handling treatment in my opinion.
gwargh
1 / 5 (1) Apr 12, 2011
Plenty of misunderstanding here... Tumors don't spread or grow if they're unable to grow, so angiogenesis (creation of NEW blood vessels) is critical in cancers metastasizing. This drug aims to prevent creation of new blood vessels, so it's a great treatment for anyone who isn't recovering from serious injuries or actively growing. It should not kill of any of the surrounding tissue.
nanotech_republika_pl
not rated yet Apr 16, 2011
qwargh, argue with this news
http://www.physor...643.html
"...the researchers say their new theory of stromal metabolic re-programming suggests that cancer cells do not need blood vessels to feed them, which explains why some angiogensis inhibitors (drugs that shut down blood vessel growth) have not worked - and, in fact, may be dangerous."